Prostate cancer: Treatment triggers for patients on active surveillance

William M. Hilton; Dipen J. Parekh

doi:10.1038/nrurol.2010.235

Prostate cancer: Treatment triggers for patients on active surveillance

William M. Hilton, Dipen J. Parekh

Urology

Research output: Contribution to journal › Short survey › peer-review

Abstract

Active surveillance (AS) is an option for low-risk prostate cancer. Accurate risk assessment is paramount to select patients for definitive intervention and to avoid overtreatment. Although inaccurate, PSA and Gleason score changes remain common treatment triggers. Biopsy before AS is initiated could avoid misclassification and the need for serial biopsy.

Original language	English (US)
Pages (from-to)	126-127
Number of pages	2
Journal	Nature Reviews Urology
Volume	8
Issue number	3
DOIs	https://doi.org/10.1038/nrurol.2010.235
State	Published - Apr 2011

ASJC Scopus subject areas

Urology

Access to Document

10.1038/nrurol.2010.235

Cite this

@article{e00904d579eb4013abf61acb7a80cc9b,

title = "Prostate cancer: Treatment triggers for patients on active surveillance",

abstract = "Active surveillance (AS) is an option for low-risk prostate cancer. Accurate risk assessment is paramount to select patients for definitive intervention and to avoid overtreatment. Although inaccurate, PSA and Gleason score changes remain common treatment triggers. Biopsy before AS is initiated could avoid misclassification and the need for serial biopsy.",

author = "Hilton, {William M.} and Parekh, {Dipen J.}",

year = "2011",

month = apr,

doi = "10.1038/nrurol.2010.235",

language = "English (US)",

volume = "8",

pages = "126--127",

journal = "Nature Reviews Urology",

issn = "1759-4812",

publisher = "Nature Publishing Group",

number = "3",

}

TY - JOUR

T1 - Prostate cancer

T2 - Treatment triggers for patients on active surveillance

AU - Hilton, William M.

AU - Parekh, Dipen J.

PY - 2011/4

Y1 - 2011/4

N2 - Active surveillance (AS) is an option for low-risk prostate cancer. Accurate risk assessment is paramount to select patients for definitive intervention and to avoid overtreatment. Although inaccurate, PSA and Gleason score changes remain common treatment triggers. Biopsy before AS is initiated could avoid misclassification and the need for serial biopsy.

AB - Active surveillance (AS) is an option for low-risk prostate cancer. Accurate risk assessment is paramount to select patients for definitive intervention and to avoid overtreatment. Although inaccurate, PSA and Gleason score changes remain common treatment triggers. Biopsy before AS is initiated could avoid misclassification and the need for serial biopsy.

UR - http://www.scopus.com/inward/record.url?scp=79952708560&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952708560&partnerID=8YFLogxK

U2 - 10.1038/nrurol.2010.235

DO - 10.1038/nrurol.2010.235

M3 - Short survey

C2 - 21243020

AN - SCOPUS:79952708560

VL - 8

SP - 126

EP - 127

JO - Nature Reviews Urology

JF - Nature Reviews Urology

SN - 1759-4812

IS - 3

ER -

Prostate cancer: Treatment triggers for patients on active surveillance

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this